Bernardi, E.; Camporese, G.; Bortoluzzi, C.; Noventa, F.; Ceccato, D.; Tonello, C.; Vohong, S.; Campello, E.; Simion, C.; Imbalzano, E.;
et al. Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project. Life 2022, 12, 1725.
https://doi.org/10.3390/life12111725
AMA Style
Bernardi E, Camporese G, Bortoluzzi C, Noventa F, Ceccato D, Tonello C, Vohong S, Campello E, Simion C, Imbalzano E,
et al. Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project. Life. 2022; 12(11):1725.
https://doi.org/10.3390/life12111725
Chicago/Turabian Style
Bernardi, Enrico, Giuseppe Camporese, Cristiano Bortoluzzi, Franco Noventa, Davide Ceccato, Chiara Tonello, Stefania Vohong, Elena Campello, Chiara Simion, Egidio Imbalzano,
and et al. 2022. "Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project" Life 12, no. 11: 1725.
https://doi.org/10.3390/life12111725
APA Style
Bernardi, E., Camporese, G., Bortoluzzi, C., Noventa, F., Ceccato, D., Tonello, C., Vohong, S., Campello, E., Simion, C., Imbalzano, E., Di Micco, P., Callegari, E., & Simioni, P.
(2022). Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project. Life, 12(11), 1725.
https://doi.org/10.3390/life12111725
